Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

Absztrakt
Leírás
Kulcsszavak
Forrás
Drugs in Context. -7 (2018), p. 1-8. -Drugs Context. - 1745-1981. - 1740-4398